We're a URAC-accredited pharmacy operating as a specialty pharmacy inside QSC's Virtual Hospital Model. URAC Specialty Pharmacy Services accreditation is in progress. We're seeking limited-distribution and REMS-network access for therapies whose patients we already serve — or could serve better than the incumbent network. We are not asking partners to lower the safety bar. We are asking to be measured fairly against it.
What we're asking
A formal, criteria-based evaluation. Not a form-letter exchange.
We are requesting a criteria-based evaluation of QuantifyRx and the QSC Virtual Hospital Model for inclusion in your specialty network — reviewed against the same standards you apply to any candidate organization. Specifically:
Written network qualification criteria.
The current, documented criteria you use to evaluate specialty providers for your network — LDD or REMS-required.
A formal evaluation meeting.
A structured review of QuantifyRx and QSC against those criteria: clinical operations, REMS readiness, reporting, patient safety, cold chain.
A defined decision timeline.
A reasonable, written timeline for evaluation and a documented decision — yes, no, or specific gaps to close.
Reviewer of record.
The name and role of the reviewer(s) accountable for the evaluation decision.
Payer-client transparency.
Acknowledgment that our self-funded plan clients will be informed of the evaluation status and the rationale for any denial. Our plan sponsors are accountable for their members' outcomes; they have a legitimate interest in how their chosen specialty partner is evaluated.
Download the capabilities packet.
Two public PDFs you can forward internally without asking us first. The full clinical operations packet (the one we send to manufacturer access committees) is available on request.
“We are not asking partners to lower the safety bar for high-risk therapies. We are asking to be measured fairly against it.” — Liane Parker, RN, CPHM · Co-Founder & Chief Clinical Operating Officer, Quantify Specialty Care
Manufacturer FAQ
Questions from manufacturer access teams.
Direct answers to the questions LDD review committees ask before scheduling a formal evaluation. For the full clinical capabilities packet, see the asks above or email liane@quantifysc.com.
Who is the legal entity behind QuantifyRx?
UrgentMedRx, LLC, doing business as QuantifyRx. URAC pharmacy accreditation MSP010001 and all state pharmacy licensure are held in the legal name UrgentMedRx, LLC. QuantifyRx is the trade name and a wholly-owned subsidiary brand of Quantify Specialty Care.
What therapeutic categories does QuantifyRx serve today?
Specialty infusion (buy-and-bill and home infusion), buy-and-bill injectables, REMS-required biologics, oral specialty oncology, and rare-disease therapies routed to the self-funded plans Quantify Specialty Care supports. The pharmacy operates inside QSC's Virtual Hospital Model — 24/7 Command Center, 1:1 bedside RNs, continuous physiologic monitoring — which makes us a fit for high-touch, high-risk therapies that traditional dispense-and-ship pharmacies aren't built for.
What is your patient population?
Members of self-funded employer health plans nationwide. We are not in network with fully-insured commercial plans or Medicare. Our plan-sponsor footprint includes large public-sector employer plans, national retail employers, captives, and multi-employer trusts. Combined book represents a sample of $88.9M+ in annual savings against incumbent specialty networks across 130+ self-funded clients of QSC.
What clinical infrastructure supports dispensing?
Every QuantifyRx fill is wrapped in QSC's Virtual Hospital Model: a 24/7 Virtual Command Center with continuous RN oversight, 1:1 bedside RN in the home, continuous physiologic monitoring via cellular IV pumps, wearable smart patches, and cellular-connected home vitals. Anaphylaxis-trained RNs and standardized epinephrine kits on every high-risk infusion. SDOH coordination by a dedicated Resource Coordinator team.
What data can manufacturer partners receive?
Patient-level monthly outcomes with full traceability: adherence (PDC), persistence, time-on-therapy, abandonment, baseline drift, AE/ER avoidance, REMS-relevant safety events, and SDOH interventions. Schema is yours. Cadence is monthly. Available under data partnership agreement.
How does cold chain work?
All temperature-sensitive biologics ship in Ember Cube active-refrigerated containers. 2–8°C maintained continuously for 72+ hours, onboard refrigeration (no dry ice), real-time GPS, continuous temperature and humidity logging. Every shipment generates a manufacturer-readable chain-of-custody log — temperature curve, humidity curve, GPS trace, delivery confirmation — available monthly.
What are you requesting from manufacturers?
A formal, criteria-based evaluation for inclusion in your limited-distribution or REMS-certified specialty network — reviewed against the same standards you apply to any candidate organization. Specifically: written network qualification criteria, a formal evaluation meeting, a defined decision timeline, a named reviewer of record, and acknowledgment that our self-funded plan clients will be informed of the evaluation status. Not a form-letter exchange.
Who is the contact for network evaluation requests?
Liane Parker, RN, CPHM — Co-Founder & Chief Clinical Operating Officer, Quantify Specialty Care. Email: liane@quantifysc.com. The capabilities packet (PDF) is downloadable above.